Back to Search
Start Over
Early-life ketamine exposure attenuates the preference for ethanol in adolescent Sprague-Dawley rats
- Source :
- Behav Brain Res
- Publication Year :
- 2019
-
Abstract
- Ketamine, a noncompetitive N-methyl-d-aspartate (NMDA) receptor antagonist, produces quick and effective antidepressant results in depressed juvenile and adult individuals. The long-term consequences of using ketamine in juvenile populations are not well known, particularly as it affects vulnerability to drugs of abuse later in life, given that ketamine is also a drug of abuse. Thus, the current study examined whether early-life ketamine administration produces long-term changes in the sensitivity to the rewarding effects of ethanol, as measured using the conditioned place preference (CPP) paradigm. On postnatal day (PD) 21, juvenile male and female rats were pretreated with ketamine (0.0 or 20 mg/kg) for 10 consecutive days (i.e., PD 21-30) and then evaluated for ethanol-induced CPP (0.0, 0.125, 0.5, or 2.0 g/kg) from PD 32-39. Results revealed that early-life ketamine administration attenuated the rewarding properties of ethanol in male rats, as ketamine pretreated rats failed to exhibit ethanol-induced CPP at any dose compared to saline pretreated rats, which showed an increased preference towards the ethanol-paired compartment in a dose-dependent manner. In females, ethanol-induced CPP was generally less robust compared to males, but ketamine pretreatment resulted in a rightward shift in the dose-response curve, given that ketamine pretreated rats needed a higher dose of ethanol compared to saline pretreated rats to exhibit ethanol-induced CPP. When considered together, the findings suggest that early use of ketamine does not appear to enhance the vulnerability to ethanol later in life, but in contrast, it may attenuate the rewarding effects of ethanol.
- Subjects :
- Male
medicine.drug_class
medicine.medical_treatment
Conditioning, Classical
Drug-Seeking Behavior
Pharmacology
Article
Rats, Sprague-Dawley
03 medical and health sciences
Behavioral Neuroscience
chemistry.chemical_compound
0302 clinical medicine
Reward
medicine
Animals
Ketamine
Saline
030304 developmental biology
0303 health sciences
Ethanol
business.industry
Anhedonia
Receptor antagonist
Conditioned place preference
chemistry
NMDA receptor
Antidepressant
Female
medicine.symptom
business
Excitatory Amino Acid Antagonists
030217 neurology & neurosurgery
medicine.drug
Subjects
Details
- ISSN :
- 18727549
- Volume :
- 389
- Database :
- OpenAIRE
- Journal :
- Behavioural brain research
- Accession number :
- edsair.doi.dedup.....ab389ea8a7bdaf0add655136382e4de6